v3.26.1
Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balances at Dec. 31, 2024 $ 438,211 $ (891) $ (439,494) $ (2,174)
Balance, shares at Dec. 31, 2024 135,537 36,913        
Issue costs on issuance of common stock, preferred stock and associated warrants on underwritten offering, net of expenses (248) (248)
Exercise of Pre-Funded Warrants
Exercise of Pre-Funded Warrants, shares   15,277        
Issue of common stock on Securities Purchase Agreement
Issue of common stock on Securities Purchase Agreement, shares   758        
Stock-based compensation 1,666 1,666
Issue of Series C preferred stock in Securities Purchase Agreement $ 1 999 1,000
Issue of Series C preferred stock in Securities Purchase Agreement, shares 1,000,000          
Series C Preferred stock conversions $ (1) 1
Series C Preferred stock conversions, shares (1,000,000) 11,042        
Issue of Series D preferred stock in Securities Purchase Agreement $ 2 1,892 1,894
Issue of Series D preferred stock in Securities Purchase Agreement, shares 2,100,000          
Series D Preferred stock conversions $ (2) $ 1 1
Series D Preferred stock conversions, shares (1,745,262) 799,912        
Issue of Series E preferred stock in Securities Purchase Agreement $ 1 999 1,000
Issue of Series E preferred stock in Securities Purchase Agreement, shares 1,000,000          
Unrealized foreign exchange on intercompany loans (2,380) (2,380)
Translation adjustment 2,385 2,385
Deconsolidation of wholly-owned foreign operation 886 (886)
Loss for the period (81) (81)
Balances at Mar. 31, 2025 $ 1 $ 1 443,521 (440,461) 3,062
Balance, shares at Mar. 31, 2025 1,490,275 863,902        
Balances at Dec. 31, 2024 438,211 (891) (439,494) (2,174)
Balance, shares at Dec. 31, 2024 135,537 36,913        
Unrealized foreign exchange on intercompany loans           (2,380)
Loss for the period           (1,399)
Balances at Jun. 30, 2025 $ 3 $ 2 445,405 (441,779) 3,631
Balance, shares at Jun. 30, 2025 3,135,537 1,583,965        
Balances at Mar. 31, 2025 $ 1 $ 1 443,521 (440,461) 3,062
Balance, shares at Mar. 31, 2025 1,490,275 863,902        
Issue costs on issuance of common stock, preferred stock and associated warrants on underwritten offering, net of expenses 21 21
Stock-based compensation 7 7
Series D Preferred stock conversions
Series D Preferred stock conversions, shares (354,738) 162,588        
Loss for the period (1,318) (1,318)
Issue of common stock and pre-funded warrants in Securities Purchase Agreement In Private Placement, net of expenses
Issue of common stock and pre-funded warrants in Securities Purchase Agreement In Private Placement, net of expenses, shares   940        
Issue of Series F preferred stock in Securities Purchase Agreement $ 3 2,997 3,000
Issue of Series F preferred stock in Securities Purchase Agreement, shares 3,000,000          
Series E Preferred stock conversions $ (1) $ 1
Series E Preferred stock conversions, shares (1,000,000) 458,333        
Exercise of Warrants (1,100) (1,100)
Exercise of Warrants, shares   98,202        
Preferred stock dividends (41) (41)
Balances at Jun. 30, 2025 $ 3 $ 2 445,405 (441,779) 3,631
Balance, shares at Jun. 30, 2025 3,135,537 1,583,965        
Balances at Dec. 31, 2025 $ 5 461,287 (39) (454,411) 6,842
Balance, shares at Dec. 31, 2025 135,537 5,400,320        
Stock-based compensation 1 1
Translation adjustment 9 9
Loss for the period (197) (197)
Preferred stock dividends (20) (20)
Issue of common stock on warrant exchange agreement 125 125
Issue of common stock on Warrant Exchange Agreements, shares   119,136        
Balances at Mar. 31, 2026 $ 5 461,393 (30) (454,608) 6,760
Balance, shares at Mar. 31, 2026 135,537 5,519,456        
Balances at Dec. 31, 2025 $ 5 461,287 (39) (454,411) 6,842
Balance, shares at Dec. 31, 2025 135,537 5,400,320        
Loss for the period           (602)
Balances at Jun. 30, 2026 $ 7 462,166 (455,013) 7,160
Balance, shares at Jun. 30, 2026 135,537 6,622,794        
Balances at Mar. 31, 2026 $ 5 461,393 (30) (454,608) 6,760
Balance, shares at Mar. 31, 2026 135,537 5,519,456        
Stock-based compensation 1 1
Translation adjustment 30 30
Loss for the period (405) (405)
Preferred stock dividends (20) (20)
Issue of common stock in Securities Purchase Agreement In Private Placement, net of expenses $ 2 792 794
Issue of common stock in Securities Purchase Agreement In Private Placement, net of expenses, shares   1,103,338        
Balances at Jun. 30, 2026 $ 7 $ 462,166 $ (455,013) $ 7,160
Balance, shares at Jun. 30, 2026 135,537 6,622,794